OPC Pharmaceutical Joint Stock Company (HOSE: OPC)
24,900
Open25,000
High25,000
Low24,900
Vol700
Market Cap.1,594.87
Remain Bid5,700
Remain Ask12,600
52Wk High25,000
52Wk Low22,400
52Wk Avg Vol4,871
Foreign Buy-
Frgn Owned(%)0.74
Dividend1,500
Dividend Yield0.06
Beta-0.21
EPS1,917
P/E13.04
F P/E9.05
BVPS13,805
P/B1.81
- Overview
- Trading
- Technical Analysis
- Financials
- Profile
- News & Events
- Industry Peers
- Documents
- Internal Trading
- Bonds
| Date | Close | Change | Volume |
|---|---|---|---|
| 04/17/2024 | 24,900 | -100 (-0.40%) | 700 |
| 04/16/2024 | 25,000 | 0 (0.00%) | 1,700 |
| 04/15/2024 | 25,000 | 1,000 (+4.17%) | 5,200 |
| 04/12/2024 | 24,000 | 0 (0.00%) | 2,400 |
| 04/11/2024 | 24,000 | 400 (+1.69%) | 5,600 |
| 09/14/2023 | OPC: Change in personnel |
| 08/29/2023 | OPC: Change in personnel |
| 08/15/2023 | OPC: Notification insider transaction |
| 07/27/2023 | OPC: OPC signs Auditing Contract |
| 07/25/2023 | OPC: Approving the transaction with related parties in 2023 |
| 05/17/2023 | OPC Dividend payment in cash with 5.00% for 2022 (Record date) |
| 05/17/2023 | OPC Dividend payment in cash with 5.00% for 2022 |
| 04/19/2023 | OPC Dividend payment in cash with 10.00% for 2022 |
| 04/19/2023 | OPC Dividend payment in cash with 10.00% for 2022 (Record date) |
| 07/21/2022 | OPC Bonus share issue with 141.00% |
| 04/08/2024 | 2024 Annual Shareholders’Meeting Documents |
| 04/12/2024 | Annual report 2023 |
| 03/22/2024 | Explanation for FS 2023 |
| 03/22/2024 | Corporate Governance Report 2023 (Adjust) |
| 03/22/2024 | Audited Parent Company FS 2023 |
Name: OPC Pharmaceutical Joint Stock Company
Abbreviation:OPC
Address: 1017 Hong Bang Street, Ward 12 District 6 Ho Chi Minh
Telephone: (84.28) 3751 7111
Fax: (84.28) 3875 2048
Email:info@opcpharma.com
Website:http://www.opcpharma.com
Exchange: HOSE
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date: 10/30/2008
Chartered capital: 265,772,800,000
Listed shares: 64,050,892
Shares outstanding: 64,050,892
Status: Operating
Tax code: 0302560110
Establishment license: 138/QĐ-TTg
Issued date: 02/08/2002
Business license: 4103000893
Issued date: 03/25/2002
Main business scope:
- Growing and processing pharmaceutical materials.
- Manufacturing and trading pharmaceutical products, materials, machinery, healthcare equipment, chemicals, cosmetics, food and others products.
- Importing and exporting products different from pharmacy.
- Others under business license.
- October 24, 1977: Pharmaceutical factory TW 26-OPC, the precursor of the company, was established;
- April , 2006: Increased the charter capital to VND40 billion;
- February 2007: Increased the charter capital to VND60 billion;
- July , 2007: Increased the charter capital to VND78 billion;
- January 2008: Increased the charter capital to VND81,9 billion;
- October 30, 2008: Traded on Ho Chi Minh Stock Exchange (HOSE);
- October 2011: Increased the charter capital to VND122,848 billion;
- August 2012: Increased the charter capital to VND128,568 billion;
- December 2014: Increased the charter capital to VND192,851 billion;
- August 2015: Increased the charter capital to VND202,493 billion;
- December 2005: Increased the charter capital to VND253,116 billion;
- August, 2018: Increased the charter capital to VND265,772 billion;
- August 25, 2020: Increased the charter capital to VND265,772,800,000;
- 04/27/2024 OPC General Meeting of Shareholders for 2024
- 05/17/2023 OPC Dividend payment in cash with 5.00% for 2022 (Record date)
- 05/17/2023 OPC Dividend payment in cash with 5.00% for 2022
- 04/27/2023 OPC General Meeting of Shareholders for 2023
- 04/19/2023 OPC Dividend payment in cash with 10.00% for 2022
| Items | Unit |
|---|---|
| Price | VND |
| Volume | Shares |
| Foreigner's, Yield | % |
| Mkt Cap | bVND |
| Financial indicators | mVND |
| EPS, BVPS, Dividend | VND |
| P/E, F P/E, P/B | Times |
| ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
